Last updated: March 30, 2022
Sponsor: Arcensus GmbH
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05305729
MetaPrint-2021
Ages > 2 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Informed consent is obtained from the participant or from the parent/ legal guardian
- The participant is 2 months or older
- The participant is diagnosed with a genetic disease
- The participant is a first degree relative of a subject diagnosed with a geneticdisease
Exclusion
Exclusion Criteria:
- Informed consent is not obtained from the participant or from the parent/ legalguardian
- The participant is younger than 2 months
- The participant is not diagnosed with a genetic disease
- The participant is not a first degree relative of a subject diagnosed with a geneticdisease
Study Design
Total Participants: 10000
Study Start date:
March 01, 2021
Estimated Completion Date:
March 31, 2026
Connect with a study center
University Hospital Center Mother Teresa
Tirana, 1000
AlbaniaActive - Recruiting
The Children's hospital & Institute of child health
Lahore, Punjab 54000
PakistanActive - Recruiting
Pakistan Institute of Medical Sciences (PIMS)
Islamabad, 4485
PakistanActive - Recruiting
Children's Hospital & The Institute of Child Health
Multan, 60000
PakistanActive - Recruiting
Khyber institute of Child Health and Children Hospital (KICH)
Peshawar, 25100
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.